Titan Biotech Ltd

Titan Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Titan Biotech Ltd

₹ 766 1.12%
22 Nov - close price
titanbiotechltd.com BSE: 524717
About

Incorporated in 1992, Titan Biotech
Ltd manufacturer and exporter of
the Biological products[1]

Key Points

Business Overview:[1]
TBL is an ISO 9001:2008 Certified & cGMP facilitated manufacturer & exporter of biological products used in the fields of Pharmaceutical, Nutraceutical, Food & Beverages, Biotechnology & Fermentation, Cosmetic, Veterinary & Animal
Feed, Agriculture Industries, Microbiology Culture Media & Plant Tissue Culture Media,
etc.

Website BSE
  • Market Cap ₹ 633 Cr.
  • Current Price ₹ 766
  • High / Low ₹ 1,018 / 375
  • Stock P/E 27.6
  • Book Value ₹ 166
  • Dividend Yield 0.26 %
  • ROCE 26.0 %
  • ROE 20.2 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 22.9%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
29.66 28.97 31.09 35.00 41.83 30.33 36.84 34.75 43.43 45.98 39.92 43.11 39.89
22.89 22.49 24.09 26.93 31.35 26.19 30.00 26.86 34.71 35.38 32.85 34.86 32.13
Operating Profit 6.77 6.48 7.00 8.07 10.48 4.14 6.84 7.89 8.72 10.60 7.07 8.25 7.76
OPM % 22.83% 22.37% 22.52% 23.06% 25.05% 13.65% 18.57% 22.71% 20.08% 23.05% 17.71% 19.14% 19.45%
0.25 0.19 0.38 0.32 0.86 0.28 0.49 0.28 0.55 0.44 0.48 0.62 0.32
Interest 0.19 0.18 0.27 0.18 0.17 0.14 0.26 0.29 0.28 0.26 0.34 0.31 0.27
Depreciation 0.55 0.57 0.69 0.60 0.64 0.65 0.71 0.80 0.86 0.83 0.84 1.05 1.10
Profit before tax 6.28 5.92 6.42 7.61 10.53 3.63 6.36 7.08 8.13 9.95 6.37 7.51 6.71
Tax % 20.06% 25.17% 25.08% 24.05% 24.98% 25.62% 26.89% 23.73% 25.71% 25.63% 24.02% 24.23% 25.48%
5.01 4.43 4.80 5.78 7.90 2.70 4.64 5.41 6.03 7.38 4.84 5.70 5.00
EPS in Rs 6.06 5.36 5.81 6.99 9.56 3.27 5.61 6.55 7.30 8.93 5.86 6.90 6.05
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
27 39 40 46 52 56 58 69 122 124 144 164 169
24 36 36 42 47 49 51 59 81 92 114 130 135
Operating Profit 3 3 4 4 6 7 8 11 42 31 30 34 34
OPM % 10% 8% 10% 9% 10% 12% 13% 16% 34% 25% 21% 21% 20%
0 0 0 0 0 0 1 1 0 1 2 2 2
Interest 1 0 1 1 1 2 2 2 1 1 1 1 1
Depreciation 0 1 1 1 1 1 2 2 2 2 3 3 4
Profit before tax 2 2 2 3 3 4 4 8 39 29 28 32 31
Tax % 34% 33% 33% 33% 33% 36% 29% 25% 26% 25% 25% 25%
1 1 2 2 2 2 3 6 29 22 21 24 23
EPS in Rs 1.86 2.12 2.11 2.22 3.02 3.10 3.73 7.50 34.81 26.24 25.44 28.63 27.74
Dividend Payout % 40% 35% 36% 34% 25% 24% 0% 13% 4% 6% 7% 7%
Compounded Sales Growth
10 Years: 15%
5 Years: 23%
3 Years: 10%
TTM: 16%
Compounded Profit Growth
10 Years: 31%
5 Years: 50%
3 Years: -7%
TTM: 22%
Stock Price CAGR
10 Years: 35%
5 Years: 83%
3 Years: 41%
1 Year: 84%
Return on Equity
10 Years: 23%
5 Years: 27%
3 Years: 23%
Last Year: 20%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 7 7 8 8 8 8 8 8 8 8 8 8 8
Reserves 7 8 13 14 15 17 23 30 58 78 98 120 129
4 7 8 11 22 25 22 18 10 9 9 8 3
4 6 5 6 5 5 6 10 10 13 16 15 26
Total Liabilities 22 28 34 39 50 55 60 65 86 108 131 152 166
4 11 11 10 11 11 26 25 27 35 36 52 57
CWIP 7 0 1 5 9 13 0 0 0 4 13 3 2
Investments 0 0 0 1 1 1 1 1 1 4 12 23 12
12 17 21 23 29 29 33 39 58 65 70 74 95
Total Assets 22 28 34 39 50 55 60 65 86 108 131 152 166

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1 -0 -2 5 -0 2 6 7 18 22 21 21
-1 -2 -3 -5 -7 -5 -4 -1 -4 -16 -21 -20
1 2 3 2 8 0 -2 -6 -10 -4 -2 -3
Net Cash Flow 2 -0 -2 2 2 -3 1 0 4 2 -2 -2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 35 52 58 46 44 53 49 55 48 48 53 42
Inventory Days 112 97 134 118 155 202 238 244 177 206 179 208
Days Payable 31 21 17 18 13 12 25 36 18 25 27 15
Cash Conversion Cycle 116 128 175 145 186 243 262 263 207 230 205 234
Working Capital Days 76 86 144 115 137 158 157 149 107 138 127 128
ROCE % 16% 14% 14% 12% 13% 13% 13% 18% 61% 35% 28% 26%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
55.88% 55.88% 55.88% 55.87% 55.87% 55.87% 55.87% 55.87% 55.87% 55.87% 55.87% 55.87%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.23% 0.00% 0.00%
44.12% 44.12% 44.12% 44.11% 44.11% 44.12% 44.13% 44.13% 44.12% 43.90% 44.12% 44.13%
No. of Shareholders 19,68020,09720,23120,26418,86618,75218,10617,45515,75615,87615,85015,700

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports